triumph-1 trial retatrutide A summary slide of the data presented today by Dr. Ania Jastreboff at #ADA2026 🚨 TRIUMPH-1: Phase 3 Obesity with Retatrutide 🚨 Retatrutide 💉, a once-weekly triple hormone receptor ⭐️topline results from TRIUMPH-1, a

Harpreet Singh Bajaj, MD, MPH, an endocrinologist at LMC Diabetes & Endocrinology in Toronto, Canada, will present the primary results of the first phase 3 study of retatrutide in patients with type 2 diabetes, the TRANSCEND-T2D-1 trial

Skeletal muscle has a high metabolic demand

Liraglutide vs Semaglutide: How the Two GLP-1 Medications Compare Daily vs

And then, uh Evan, quickly, uh I want to get you out on a question that I'm going to guess you are asked by investors, which is okay, talk about GLP-1s, this is all we talk about

Of the currently available classes of glucose-lowering therapies, the glucagonlike peptide-1 (GLP-1) receptor agonist class of medications has gained popularity in recent years